Morbidity and mortality in hemodialysis patients with and without erythropoietin treatment: a controlled study.
Bahlmann
J
J
Abteilung Nephrologie, Medizinische Hochschule, Hannover, FRG.
Schöter
K H
KH
Scigalla
P
P
Gurland
H J
HJ
Hilfenhaus
M
M
Koch
K M
KM
Muthny
F A
FA
Neumayer
H H
HH
Pommer
W
W
Quelhorst
E
E
D000328:Adult; D000368:Aged; D000740:Anemia / Q000188:drug therapy*; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006454:Hemoglobins / Q000032:analysis; D006801:Humans; D006973:Hypertension / Q000209:etiology; D008297:Male; D008875:Middle Aged; D011994:Recombinant Proteins / Q000627:therapeutic use; D006435:Renal Dialysis / Q000009:adverse effects* / Q000401:mortality
D006454:Hemoglobins; D011994:Recombinant Proteins; D004921:Erythropoietin